Trademark: 75684834
Status Date
Thursday, December 16, 2021
Registration Number
2359863
Registration Date
Tuesday, June 20, 2000
Filing Date
Monday, April 19, 1999
Published for Opposition
Tuesday, March 28, 2000
1 Cell lines for use in the production of recombinant proteins for medical and clinical use and cells for medical or clinical use, including an insect line, a baculovirus-suspectible insect cell line, and a spodoptera frugiperda cell line having one or more of the following characteristics - cells which are genetically and morphologically distinct from the parent of Sf9 cells, cells which replicate in serum-free medium, cells which grow as a suspension of single cells without significant clumping, cells which grow exponentially with a cell doubling time of 18 to 24 hours, cells which can be passed continuously for at least 6 months while maintaining a high level of viability (>98%), cells which are highly permissive to infection with californica npv baculoviruses resulting in high-titered virus stocks, cells which are useful for the production of recombinant DNA gene cell products following infection with baculovirus vectors, cells which are useful for the production and plaque-isolation of genetically engineered baculovirus cells which meet the general identity and safety requirements for cells set by government regulatory agencies, and cells which are suitable for the manufacture of biological pharmaceutical products following cGMP standards
5 Cell lines for use in the production of recombinant proteins for scientific, laboratory and medical research and cells for research of a scientific, laboratory or medical nature, including an insect line, a baculovirus-suspectible insect cell line, and a spodoptera frugiperda cell line having one or more of the following characteristics - cells which are genetically and morphologically distinct from the parent Sf9 cells, cells which replicate in serum-free medium, cells which grow as a suspension of single cells without significant clumping, cells which grow exponentially with a cell doubling time of 18 to 24 hours, cells which can be passed continuously for at least 6 months while maintaining a high level of viability (>98%), cells which are highly permissive to infection with californica npv baculoviruses resulting in high-titered virus stocks, cells which are useful for the production of recombinant DNA gene cell products following infection with baculovirus vectors, cells which are useful for the production and plaque-isolation of genetically engineered baculovirus cells which meet the general identity and safety requirements for cells set by government regulatory agencies, and cells which are suitable for the manufacture of biological pharmaceutical products following cGMP standards
EXPRESS F +; EXPRESS F PLUS
Dec 16, 2021
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Dec 16, 2021
Case Assigned To Post Registration Paralegal
Dec 16, 2021
Registered And Renewed (Second Renewal - 10 Yrs)
Dec 16, 2021
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Dec 5, 2021
Case Assigned To Post Registration Paralegal
Dec 3, 2021
Petition To Director - Granted
Nov 30, 2021
Assigned To Petition Staff
Apr 21, 2021
Teas Petition To Director Received
Apr 1, 2021
Post Registration Action Mailed - Sec. 8 & 9
Jan 25, 2021
Teas Response To Office Action-Post Reg Received
Oct 15, 2020
Post Registration Action Mailed - Sec. 8 & 9
Sep 30, 2020
Case Assigned To Post Registration Paralegal
Aug 20, 2020
Teas Section 8 & 9 Received
Jan 8, 2020
Review Of Correspondence Complete - Address Updated
Dec 10, 2019
Correspondence Received In Law Office
Jun 20, 2019
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Sep 19, 2018
Assignment Of Ownership Not Updated Automatically
Jan 4, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 4, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 2, 2017
Assignment Of Ownership Not Updated Automatically
Oct 11, 2010
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 11, 2010
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 21, 2010
Registered And Renewed (First Renewal - 10 Yrs)
May 21, 2010
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
May 18, 2010
Teas Section 8 & 9 Received
Mar 1, 2007
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Feb 20, 2007
Assigned To Paralegal
Dec 19, 2006
Registered - Sec. 8 (6-Yr) & Sec. 15 Filed
Dec 19, 2006
Teas Section 8 & 15 Received
Mar 23, 2006
Case File In Ticrs
Jun 20, 2000
Registered-Principal Register
Mar 28, 2000
Published For Opposition
Feb 25, 2000
Notice Of Publication
Jan 28, 2000
Approved For Pub - Principal Register
Jan 28, 2000
Use Amendment Accepted
Oct 18, 1999
Correspondence Received In Law Office
Sep 16, 1999
Non-Final Action Mailed
Sep 3, 1999
Assigned To Examiner
Aug 20, 1999
Assigned To Examiner
Jul 30, 1999
Amendment To Use Processing Complete
Jun 30, 1999
Use Amendment Filed
Trademark Alertz updated from USPTO on 2030-01-24
